Learn / GPCR
NASDAQ: GPCR
Structure Therapeutics (GPCR) stock, explained like you're 5
Structure Therapeutics trades on the Nasdaq under the ticker GPCR. It is a small cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 1.8 billion dollars.
- Ticker
- GPCR
- Exchange
- Nasdaq
- Sector
- Healthcare
- Industry
- Pharmaceutical Preparations
- Size
- Small cap, about 1.8 billion dollars
Is Structure Therapeutics a small, medium or large cap company?
No. Structure Therapeutics is a small cap stock, not a large cap. Its market cap, which is the total value of all its shares, is about 1.8 billion dollars.
Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.
How Structure Therapeutics makes money
- Selling medicines, medical devices or healthcare services.
- Insurance premiums or hospital and clinic fees.
- Research and licensing deals.
What moves GPCR stock
- Results from clinical trials and approvals from regulators.
- Drug prices, insurance rules and government policy.
- Patents running out and new competing treatments.
In the news lately
- Structure Therapeutics (GPCR) Stock May Be A Bargain Given Its Asset Base (Yahoo Finance)
- Structure Therapeutics stock hits 52 week low at $21.45 (Investing.com)
- Structure Therapeutics (NasdaqGM:GPCR) Stock Forecast & Analyst Predictions (Simply Wall Street)
- Structure Therapeutics falls on obesity drug data (GPCR:NASDAQ) (Seeking Alpha)
- GPCR Oct 2026 57.500 put (GPCR261016P00057500) stock price, news, quote and history (Yahoo Finance UK)
Follow GPCR in your daily brief
Each trading day at 5 PM ET we post what happened to Structure Therapeutics and why it matters, in simple words. Free.
Start my free briefKey terms to know before you follow GPCR
Questions about Structure Therapeutics stock
What does Structure Therapeutics do?
Structure Therapeutics trades on the Nasdaq under the ticker GPCR. It is a small cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 1.8 billion dollars.
What is the ticker symbol for Structure Therapeutics?
Structure Therapeutics trades under the ticker GPCR on the Nasdaq.
What is Structure Therapeutics's market cap?
Structure Therapeutics is a small cap stock with a market cap of about 1.8 billion dollars.
How does Structure Therapeutics make money?
Selling medicines, medical devices or healthcare services. Insurance premiums or hospital and clinic fees. Research and licensing deals.
What moves GPCR stock?
Results from clinical trials and approvals from regulators. Drug prices, insurance rules and government policy. Patents running out and new competing treatments.
How can I follow GPCR stock every day?
Add GPCR to your watchlist on Metric Finance. We post a free brief every trading day at 5 PM ET that explains what happened to the stocks you follow, in simple words.
Similar stocks
Educational information, not financial advice. This guide explains the business in general terms and does not include live prices.